News

The company has a strong cash position of $471m, despite a net loss of $63m in 2024, providing a long funding runway. Click ...
"FDA approves Neurelis’ nasal spray for seizures" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has b ...